AllianceBernstein’s Monte Rosa Therapeutics GLUE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $286K | Buy |
63,480
+28,340
| +81% | +$128K | ﹤0.01% | 2937 |
|
|
2025
Q1 | $163K | Hold |
35,140
| – | – | ﹤0.01% | 2974 |
|
|
2024
Q4 | $244K | Hold |
35,140
| – | – | ﹤0.01% | 2970 |
|
|
2024
Q3 | $186K | Buy |
35,140
+2,360
| +7% | +$12.5K | ﹤0.01% | 3051 |
|
|
2024
Q2 | $123K | Buy |
32,780
+9,210
| +39% | +$34.4K | ﹤0.01% | 3096 |
|
|
2024
Q1 | $166K | Hold |
23,570
| – | – | ﹤0.01% | 2959 |
|
|
2023
Q4 | $133K | Hold |
23,570
| – | – | ﹤0.01% | 3030 |
|
|
2023
Q3 | $113K | Buy |
23,570
+1,720
| +8% | +$8.24K | ﹤0.01% | 3039 |
|
|
2023
Q2 | $150K | Buy |
21,850
+7,650
| +54% | +$52.4K | ﹤0.01% | 3032 |
|
|
2023
Q1 | $111K | Buy |
14,200
+1,800
| +15% | +$14K | ﹤0.01% | 3017 |
|
|
2022
Q4 | $94.4K | Buy |
+12,400
| New | +$94.4K | ﹤0.01% | 3117 |
|
|
2022
Q2 | – | Sell |
-81,302
| Closed | -$1.14M | – | 3304 |
|
|
2022
Q1 | $1.14M | Sell |
81,302
-8,867
| -10% | -$124K | ﹤0.01% | 2366 |
|
|
2021
Q4 | $1.84M | Buy |
90,169
+5,722
| +7% | +$117K | ﹤0.01% | 2184 |
|
|
2021
Q3 | $1.88M | Sell |
84,447
-54,648
| -39% | -$1.22M | ﹤0.01% | 2196 |
|
|
2021
Q2 | $3.16M | Buy |
+139,095
| New | +$3.16M | ﹤0.01% | 1891 |
|